Cost-effectiveness analysis of liposomal irinotecan in combination with oxaliplatin, 5-fluorouracil and leucovorin (NALIRIFOX) for the first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas in Greece
George Gourzoulidis, Vassiliki Chotzagiannoglou, Andriani Angelopoulou, Eleana Solakidou et autres